Study guide
12.1 Delirium, Agitation, Sedation & Pain
AACN CCRN Adult
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Strategy
1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy
2 Cardiovascular I — Hemodynamics & Shock
2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology
3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias
3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS
4 Respiratory I -- Failure, ABGs & Acute Conditions
4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma
5 Respiratory II — Mechanical Ventilation
5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications
6 Endocrine Emergencies
6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises
7 Renal & Genitourinary
7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy
8 Gastrointestinal
8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition
9 Hematology, Immunology & Integumentary
9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries
10 Neurological I — Stroke, TBI & ICP
10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring
11 Neurological II & Musculoskeletal
11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal
12 Behavioral & Psychosocial
12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety
13 Multisystem I — Sepsis & MODS
13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response
14 Multisystem II — Trauma, Burns & Toxicology
14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies
15 Synergy Model, Advocacy & Caring
15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices
16 Collaboration, Systems Thinking & Diversity
16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning
17 Clinical Inquiry, Ethics & End-of-Life
17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care
12.1 Delirium, Agitation, Sedation & Pain
Key Takeaways Explain This Topic AI
CAM-ICU is positive when Feature 1 (acute onset or fluctuating course) AND Feature 2 (inattention) are present, PLUS Feature 3 (altered level of consciousness) OR Feature 4 (disorganized thinking).
Hypoactive delirium is the most common ICU subtype and carries the worst prognosis because it is quiet and easily missed.
Target light, goal-directed sedation at RASS 0 to -2; deep sedation increases delirium, ventilator days, and mortality.
Propofol-related infusion syndrome (PRIS) causes metabolic acidosis, rhabdomyolysis, hyperkalemia, and cardiac failure at high doses (>4-5 mg/kg/hr) beyond 48 hours.
CPOT (0-8, >2 significant) and BPS (3-12, >5 unacceptable) assess pain in nonverbal patients; benzodiazepines are the strongest modifiable delirium risk.
Last updated: July 2026
ICU Delirium — Recognition and Subtypes
Delirium is an acute, fluctuating disturbance of attention and awareness with disorganized thinking that is driven by an underlying medical cause. It affects up to 80% of mechanically ventilated ICU patients and is an independent predictor of increased mortality, more ventilator days, longer length of stay, and long-term cognitive impairment resembling mild dementia. The CCRN blueprint files delirium under Behavioral/Psychosocial content and expects you to separate it from dementia (chronic, slowly progressive, attention preserved early) and depression (low mood, but orientation intact).
Three motor subtypes exist. Hyperactive delirium (agitation, pulling at lines, combativeness) is the most recognized but least common. Hypoactive delirium (withdrawn, flat, slowed, quietly inattentive) is the most common and most dangerous because it is easily mistaken for a calm, cooperative patient and carries the worst prognosis. Mixed delirium fluctuates between the two. Because hypoactive delirium hides in plain sight, routine objective screening — not clinical gestalt — is required.
Screening: CAM-ICU and ICDSC
The CAM-ICU (Confusion Assessment Method for the ICU) is the most heavily tested tool. Delirium is present when the patient shows Feature 1 (acute change or fluctuating course) AND Feature 2 (inattention), PLUS either Feature 3 (altered level of consciousness, i.e., a RASS other than 0) OR Feature 4 (disorganized thinking) . A patient too deeply sedated to participate (RASS -4 or -5) is scored "unable to assess," not delirium-negative. The ICDSC (Intensive Care Delirium Screening Checklist) is an 8-item alternative scored across a shift, where 4 or more indicates delirium. Screen every patient at least once per shift.
Risk Factors and Prevention
Separate modifiable from non-modifiable risks — the exam rewards targeting the modifiable ones.
- Modifiable (prevent/treat) Non-modifiable (identify high risk)
- Benzodiazepines Advanced age
- Immobility and physical restraints Baseline dementia or cognitive impairment
- Sleep deprivation Severity of illness (high APACHE)
- Uncontrolled pain Emergency or major surgery
- Sensory deprivation (no glasses/hearing aids) Coma
- Dehydration and metabolic derangement Pre-existing alcohol use / hypertension
The cornerstone of prevention is the ABCDEF bundle : A ssess/treat pain, B oth spontaneous awakening trials (SAT) and spontaneous breathing trials (SBT), C hoice of analgesia/sedation (avoid benzodiazepines), D elirium assess/prevent/manage, E arly mobility and exercise, and F amily engagement. Nonpharmacologic elements — reorientation, sleep hygiene (clustering care, cutting night-time noise and light), early mobilization, restoring glasses and hearing aids, and removing tethers — are always first-line. Antipsychotics do not prevent or shorten delirium (the MIND-USA trial found haloperidol and ziprasidone no better than placebo); reserve low-dose antipsychotics for dangerous agitation that threatens safety.
Sedation — Light, Goal-Directed, Analgesia-First
Deep sedation increases delirium, ventilator days, and mortality, so the standard is light, goal-directed sedation titrated to a validated scale. The Richmond Agitation-Sedation Scale (RASS) runs from +4 (combative) to -5 (unarousable) ; the usual target is 0 to -2 unless a specific indication (severe ARDS, refractory intracranial hypertension, status epilepticus, neuromuscular blockade) requires going deeper.
- RASS Term Description
- +4 Combative Violent, immediate danger to staff
- +3 Very agitated Pulls/removes tubes or catheters; aggressive
- +2 Agitated Frequent nonpurposeful movement; vent dyssynchrony
- +1 Restless Anxious, movements not aggressive
- 0 Alert and calm —
- 1 Drowsy Sustained (>10 s) awakening, eye contact to voice
- 2 Light sedation Briefly (<10 s) awakens with eye contact to voice
- 3 Moderate Movement/eye opening to voice, no eye contact
- 4 Deep sedation No response to voice; moves to physical stimulus
- 5 Unarousable No response to voice or physical stimulus
Two strategies keep patients light: a daily spontaneous awakening trial (SAT) — pausing sedation each morning to reassess, paired with an SBT — and analgosedation (analgesia-first), treating pain before adding a hypnotic. Agitation is frequently unrelieved pain, hypoxemia, hypercapnia, or ventilator dyssynchrony, so when a ventilated patient is "fighting the vent," first rule out and treat those causes rather than reflexively deepening sedation.
Choosing a Sedative
Agent Class Key advantage Key risk
Dexmedetomidine Alpha-2 agonist Arousable, no respiratory depression, less delirium Bradycardia, hypotension, no amnesia
- Propofol GABA hypnotic Rapid on/off, easily titrated Hypotension, hypertriglyceridemia, PRIS
- Benzodiazepines GABA Anticonvulsant, amnestic More delirium, accumulation, propylene-glycol toxicity
Dexmedetomidine gives cooperative, arousable sedation with no respiratory depression and less delirium than benzodiazepines; watch for bradycardia and hypotension , and remember it provides no reliable amnesia. Propofol allows rapid titration but causes dose-dependent hypotension, hypertriglyceridemia, and — critically — propofol-related infusion syndrome (PRIS) : at high doses (>4-5 mg/kg/hr) beyond 48 hours, patients develop metabolic acidosis, rhabdomyolysis, hyperkalemia, acute kidney injury, and cardiac failure ; green urine and a rising lactate/triglyceride are warning signs. Benzodiazepines (midazolam, lorazepam) are the strongest modifiable delirium risk and are reserved for alcohol withdrawal, status epilepticus, and deep-sedation needs; continuous lorazepam can cause propylene-glycol toxicity (an anion-gap acidosis). Patients on continuous neuromuscular blockade must always receive adequate sedation and analgesia — paralytics provide neither, and awareness while paralyzed is traumatic; monitor depth with train-of-four .
Pain Assessment in the Nonverbal Patient
Self-report on a 0-10 Numeric Rating Scale is the gold standard whenever the patient can communicate. When they cannot (intubated, sedated), use a validated behavioral tool. The CPOT (Critical-Care Pain Observation Tool) scores four domains — facial expression, body movements, muscle tension, and ventilator compliance (or vocalization if extubated) — from 0-8, with >2 indicating significant pain. The BPS (Behavioral Pain Scale) scores facial expression, upper-limb movement, and ventilator compliance from 3-12, with >5 unacceptable. Vital-sign changes alone are not valid pain indicators. Assess pain first, then sedation, at regular intervals and after every intervention.